Stroke
Conditions
Keywords
Stroke, Upper limb, Somatosensation, Sensory processing, Robotic assessment, Kinematics
Brief summary
After a stroke, more than two out of three patients experience problems with upper limb movement and sensation. During the past decade, robotic technology has been increasingly used to asses these problems in a detailed and accurate manner. However, sensory processing, one of the most important sensory functions, has not been assessed using robotic technology yet. Therefore, the investigators have developed a robotic assessment of sensory processing. During this study, the investigators aim to initially validate this novel assessment. The investigators aim to examine 20 chronic stroke patients and 20 age-matched healthy controls using the robotic assessment on one hand, and a set of existing clinical assessments on the other hand. The investigators hypothesize that stroke patients will have a poorer performance on this novel robotic assessment compared to age-matched healthy controls, and that these findings are similar to what is found with existing clinical assessments.
Detailed description
Up to 70% of stroke survivors show upper limb impairments consisting of motor and/or somatosensory impairments. These impairments often persist well into the chronic stage, and may lead to significant limitations in activities of daily living and may negatively affect quality of life. It is therefore of utmost importance to accurately assess upper limb impairments. Clinical assessments exist for both motor and somatosensory function, but lack good psychometric properties. Robotic technology show promising potential and is readily available to assess motor function and proprioception. Robotic assessment for sensory processing is currently not yet available, despite being the most relevant somatosensory function. Indeed, sensory processing shows the strongest association with upper limb movement, and only shows incomplete recovery at 6 months after stroke. The investigators recently developed a novel robotic assessment of sensory processing, using the Kinarm End-Point Lab (BKIN Technologies Ltd., Canada). This cross-sectional study was set up to initially validate this novel robotic assessment and to collect pilot data to form the basis for future research. 20 chronic stroke patients and 20 age-matched controls will be recruited and will undergo extensive clinical and robotic assessment of upper limb motor and somatosensory function. The investigators hypothesize stoke patients with sensory processing deficits to have a worse performance on this novel robotic assessment compared to healthy controls and patients without sensory processing deficits. The investigators also hypothesize to see moderate to high correlations between the robotic assessment of sensory processing, and clinical assessments for both somatosensory and motor function.
Interventions
None listed
Sponsors
Universitaire Ziekenhuizen KU Leuven
KU Leuven
Study design
Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
- Stroke Patients: * At least 18 years old * A first-ever unilateral, supratentorial stroke (as defined by WHO) * In the chronic phase after stroke (i.e. being at least 6 months after stroke) * The ability to perform, at least to some extent, active shoulder abduction and wrist extension against gravity
Exclusion criteria
- Stroke Patients: * Any serious musculoskeletal and/or other neurological conditions * Serious communication or cognitive deficits * No written informed consent Inclusion Criteria - Healthy Controls: \- At least 18 years old
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Kinarm: sensory processing task | Once in the chronic phase (at least 6 months after stroke) | Newly-developed task on the Kinarm End-Point Lab used to assess passive and active sensory processing |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Kinarm: visually guided reaching | Once in the chronic phase (at least 6 months after stroke) | Assessment of motor function using a 4-target centre-out reaching task on the Kinarm End-Point Lab |
| Erasmus modified Nottingham sensory assessment | Once in the chronic phase (at least 6 months after stroke) | Clinical assessment of sensory processing with an area under the curve based scoring system, with higher scores meaning better performance |
| Tactile discrimination test | Once in the chronic phase (at least 6 months after stroke) | Clinical assessment of sensory processing with an area under the curve based scoring system, with higher scores meaning better performance |
| Tactile functional object recognition | Once in the chronic phase (at least 6 months after stroke) | Clinical assessment of sensory processing on an ordinal scale ranging from 0 to 42, with higher scores meaning better performance |
| Stereognosis section of the original Nottingham sensory assessment | Once in the chronic phase (at least 6 months after stroke) | Clinical assessment of sensory processing on an ordinal scale ranging from 0 to 22, with higher scores meaning better performance |
| Wrist position sense test | Once in the chronic phase (at least 6 months after stroke) | Clinical assessment of wrist position sense on a continuous scale, with lower scores meaning better performance |
| Kinarm: position matching task | Once in the chronic phase (at least 6 months after stroke) | Assessment of limb position sense using a 9-target mirror-matching task on the Kinarm End-Point Lab |
| Fugl-Meyer upper extremity assessment | Once in the chronic phase (at least 6 months after stroke) | Clinical assessment of motor function on an ordinal scale ranging from 0 to 66, with higher scores meaning better performance |
| Action research arm test | Once in the chronic phase (at least 6 months after stroke) | Clinical assessment of motor activity performance on an ordinal scale ranging from 0 to 57, with higher scores meaning better performance |
| Barthel index | Once in the chronic phase (at least 6 months after stroke) | Clinical assessment of activities of daily living on an ordinal scale ranging from 0 to 20, with higher scores meaning better performance |
| Montreal cognitive assessment | Once in the chronic phase (at least 6 months after stroke) | Clinical assessment of cognitive function on an ordinal scale ranging from 0 to 30, with higher scores meaning better performance |
| Star cancellation test | Once in the chronic phase (at least 6 months after stroke) | Clinical assessment of visuospatial neglect on an ordinal scale ranging from 0 to 54, with higher scores meaning better performance, and a score below 44 indicating the presence of visuospatial neglect |
| Perceptual threshold of touch | Once in the chronic phase (at least 6 months after stroke) | TENS-based assessment of exteroception on a continuous scale, with lower scores meaning better performance |
Countries
Belgium
Outcome results
None listed